We are live on
!
Find out more
HIH
HRS Investment Holdings Portfolio holdings
AUM
$77.4M
1-Year Est. Return
16.69%
This Fund
S&P 500
This Quarter
Est. Return
+2.12%
1 Year Est. Return
-16.69%
3 Year Est. Return
+21.52%
5 Year Est. Return
+29.68%
10 Year Est. Return
–
AUM
$153M
AUM Growth
+$14.1M
(+10%)
Cap. Flow
+$10.6M
Cap. Flow
% of AUM
6.94%
Top 10 Holdings %
Top 10 Hldgs %
37.72%
Holding
98
New
10
Increased
19
Reduced
9
Closed
13
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ATH
Athene Holding Ltd. Class A Common Shares
ATH
|
+$8.99M |
| 2 |
Goldman Sachs
GS
|
+$2.22M |
| 3 |
Kroger
KR
|
+$1.99M |
| 4 |
Clearway Energy Class C
CWEN
|
+$1.41M |
| 5 |
Molson Coors Class B
TAP
|
+$1.16M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$1.79M |
| 2 |
AFSI
AmTrust Financial Services, Inc.
AFSI
|
+$1.39M |
| 3 |
Virtu Financial
VIRT
|
+$1.19M |
| 4 |
Edwards Lifesciences
EW
|
+$1.1M |
| 5 |
APC
Anadarko Petroleum
APC
|
+$1.08M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 27.98% |
| 2 | Technology | 12.42% |
| 3 | Healthcare | 11.56% |
| 4 | Industrials | 10.25% |
| 5 | Consumer Staples | 8.46% |
Similar funds
SM
PGF
IRF
BRWM
EL
BA
FA
CRCM
HRS Investment Holdings's Q2 2017 Portfolio in Review
As of Q2 2017, HRS Investment Holdings held 98 positions worth $153M, up 10% from $139M the previous quarter. Its ten largest holdings account for 38% of the portfolio.
HRS Investment Holdings deployed $10.6M of net new capital in Q2 2017, opening 10 new positions and adding to 19 existing holdings. Its largest new stake was Goldman Sachs: 10,000 shares worth $2.22M.
By sector, the portfolio is most concentrated in Financials at 28% of assets, up from 22% a quarter earlier, followed by Technology and Healthcare.
On the sell side, the largest reduction was Edwards Lifesciences, an estimated $1.1M trimmed.
- HRS Investment Holdings's largest Q2 2017 buy was Goldman Sachs: 10,000 shares worth $2.22M.
- HRS Investment Holdings added most to Athene Holding Ltd. Class A Common Shares in Q2 2017, an estimated $8.99M increase.
- HRS Investment Holdings's biggest Q2 2017 reduction was Edwards Lifesciences, cutting an estimated $1.1M.
- HRS Investment Holdings fully exited Allergan plc in Q2 2017, selling an estimated $1.79M.
- HRS Investment Holdings's ten largest holdings make up 38% of its $153M portfolio in Q2 2017.
- HRS Investment Holdings opened 10 new positions and closed 13 in Q2 2017.
- HRS Investment Holdings's portfolio value rose 10% quarter-over-quarter to $153M.
Based on HRS Investment Holdings's 13F filing for Q2 2017, filed 14 Aug 2017.